Background: The association between patent foramen ovale (PFO) and migraine has been
reported. However, whether transcatheter PFO closure is effective in alleviating migraine …

Objectives: To assess the long‐term results of transcatheter patent foramen ovale (PFO)
closure on migraine headache with aura (MHA) and on the risk of recurrent stroke …

Objectives: We sought to evaluate the benefits on frequency and severity of migraine
recurrence after patent foramen ovale (PFO) closure in patients with subclinical brain lesions …

The relationship between migraine, stroke and patent foramen ovale (PFO) has been the
subject of considerable research efforts. Indeed, a lot of interest has focused on the potential …

4 mate and lamotrigine were not used [6, 7]). The trial randomised 147 patients to either
transcutaneous PFO closure with the STARFlex device or a sham procedure. One hundred …

Background: Transcatheter closure of PFO with nitinol devices may be problematic in young
patients with migraine due the risk of late erosions. Alternative devices with less amount of …

Purpose: Patent foramen ovale (PFO) closure is sometimes considered for patients (pts) with
migraine. In our institution the therapeutic choice is the result of an interplay between the …

Objectives: This single‐center, observational, prospective study evaluated the impact of
patent foramen ovale (PFO) closure on migraine attacks over time. Background: PFO closure …

Migraine is a common neuro-vascular disease with a global prevalence of about 15% and a
heavy burden. Patent foramen ovale (PFO) is the most common congenital cardiac …

This study aims to evaluate the potential of percutaneous patent foramen ovale (PFO)
closure to improve the headache in patients with migraine and PFO, and discuss the …